Respiratory syncytial virus (RVS): associated burden of illness and healthcare utilization in Ontario

Client: IQVIA Solutions Canada Inc.

Project ID: P2020-089 / 2022 0970 291 000

Research Question/Objectives: Respiratory syncytial virus (RSV) is a common respiratory virus that usually causes mild, cold-like symptoms, but can have serious consequences, especially among infants and older adults. In Canada, RSV is responsible for 1042 hospitalizations per 100,000 infants per year and over 100 hospitalizations per 100 000 of those over the age of 75 years, with mortality as high as 41% among those with underlying medical conditions. The present study aims to evaluate the direct healthcare resource utilization (HCRU) and associated costs incurred by the public payer for RSV patients in Ontario.

Research objectives:

Describe the count of patients hospitalized for RSV in Ontario.
Describe the demographic characteristics and HCRU of patients hospitalized for RSV in Ontario, overall and with specific outcomes.
Describe the direct healthcare costs of patients hospitalized for RSV in Ontario, overall and with specific outcomes, matched to controls.

Results:

December 2023